Legend Biotech Corp Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019
Legend Biotech Corp (LEGN) had Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 of $11.15 per share as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 · last filed 2026-03-10
- 2025-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $11.15.
- 2024-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $7.75.
- 2023-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $4.54.
- 2022-12-31: Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 $2.87.
| Period end | Weighted Average Exercise Price Of Share Options Exercisable In Share-based Payment Arrangement2019 |
|---|---|
| 2025-12-31 | $11.15 20-F · filed 2026-03-10 |
| 2024-12-31 | $7.75 20-F · filed 2026-03-10 |
| 2023-12-31 | $4.54 20-F · filed 2026-03-10 |
| 2022-12-31 | $2.87 20-F · filed 2025-03-11 |
| 2021-12-31 | $1.43 20-F · filed 2024-03-19 |
| 2020-12-31 | $1.07 20-F · filed 2023-03-30 |
| 2019-12-31 | $0.79 20-F/A · filed 2023-02-17 |